Skip to content

Association of cumulative LDL-C exposure and systolic blood pressure time-in-therapeutic-range with coronary lesion progression in patients with acute coronary syndrome

Association of cumulative LDL-C exposure and systolic blood pressure time-in-therapeutic-range with coronary lesion progression in patients with acute coronary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130155
Enrollment
Unknown
Registered
2026-08-17
Start date
2026-08-18
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease disorder of lipid metabolism inflammatory markers metabolic markers

Interventions

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with acute coronary syndrome (ACS), including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). All diagnoses were established in accordance with relevant guideline criteria. 2.The interval between two coronary angiographies was >=12 months. 3.At least three valid LDL-C measurements were available from baseline to follow-up for the calculation of cumulative LDL-C exposure. 4.At least three valid systolic blood pressure (SBP) measurements were available from baseline to follow-up for the calculation of SBP-TTR (time-in-therapeutic-range). 5.Complete baseline laboratory data including routine blood tests (neutrophil, lymphocyte, monocyte and platelet counts), lipid profiles (TC, TG, LDL-C, HDL-C), and fasting blood glucose, which were required to derive NLR, SII, PIV, MHR, AIP and TyG index.

Exclusion criteria

Exclusion criteria: 1.Patients with familial hypercholesterolemia (genetically confirmed or DLCN score > 8 points); 2.Patients who underwent the initial coronary angiography within 30 days after ACS onset; 3.Patients complicated with severe hepatic or renal insufficiency (eGFR 3 × ULN), malignant tumors, hematological diseases, autoimmune diseases, or acute infection; 4.Patients with a prior history of coronary artery bypass grafting (CABG); 5.Patients lost to follow-up due to non-cardiovascular causes or without complete follow-up data.

Design outcomes

Primary

MeasureTime frame
coronary lesion progression between two coronary angiographies;

Secondary

MeasureTime frame
Cumulative LDL Exposure;Systolic Blood Pressure TTR;Correlation Between the NLR, SII, PIV, MHR, AIP, and TyG Indices and Disease Progression;

Countries

China

Contacts

Public ContactJiang Yinong

The First Affiliated Hospital of Dalian Medical University

yinongjiang@126.com+86 411 83635963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026